ACRO BIOMEDICAL CO., LTD.

Since January 30, 2017, the company has focused on developing and marketing nutritional products that support wellness and a healthy lifestyle. Its revenue has come from purchasing products from three suppliers in the Republic of China (Taiwan), with one supplier accounting for all purchases in the year ended December 31, 2022. The company did not generate any revenue in the second and third quarters of 2022, or subsequent to December 31, 2022, through the date of this annual report. It also has not purchased any inventory since the second quarter of 2022. Substantially all sales to date have been of cordyceps-related products. Cordyceps is a fungus used in traditional Chinese medicine, described in old Chinese and Tibetan medical books. Cordyceps sinensis is a rare combination of a caterpillar and a fungus found at altitudes above 4500m in Sikkim. In the quarter ended June 30, 2018, the company sold metallothionein MT-3 elizer, and it considers metallothionein MT- as part of its business. The company's business plan is in preliminary stages.